ATLL

Clinical trials for ATLL explained in plain language.

Never miss a new study

Get alerted when new ATLL trials appear

Sign up with your email to follow new studies for ATLL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug combo targets Tough-to-Treat leukemia

Disease control Completed

This study tested whether adding the drug belinostat to standard zidovudine (AZT) therapy could help control adult T-cell leukemia-lymphoma (ATLL), a rare and aggressive blood cancer. Fifteen adults with ATLL received the combination treatment to see if it could eliminate cancer …

Matched conditions: ATLL

Phase: PHASE2 • Sponsor: University of Miami • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

ATLL

Get alerted when new ATLL trials appear

New drug combo targets Tough-to-Treat leukemia